Lazard Analyst Ratings
Lazard Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/27/2023 | 58.06% | Morgan Stanley | $41 → $45 | Maintains | Overweight |
10/12/2023 | 44.01% | Morgan Stanley | $42 → $41 | Maintains | Overweight |
10/10/2023 | 75.62% | JMP Securities | $53 → $50 | Maintains | Market Outperform |
10/03/2023 | 12.4% | UBS | $37 → $32 | Maintains | Neutral |
09/26/2023 | 47.52% | Morgan Stanley | $44 → $42 | Maintains | Overweight |
09/19/2023 | 12.4% | Goldman Sachs | $37 → $32 | Downgrades | Neutral → Sell |
07/31/2023 | 29.96% | UBS | $32 → $37 | Maintains | Neutral |
07/14/2023 | 51.04% | Morgan Stanley | $43 → $43 | Reiterates | Overweight → Overweight |
07/13/2023 | — | Keefe, Bruyette & Woods | Upgrades | Underperform → Market Perform | |
07/12/2023 | 51.04% | Morgan Stanley | $36 → $43 | Upgrades | Equal-Weight → Overweight |
07/10/2023 | 86.16% | JMP Securities | → $53 | Reiterates | Market Outperform → Market Outperform |
07/03/2023 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
05/22/2023 | 86.16% | JMP Securities | $53 → $53 | Reiterates | Market Outperform → Market Outperform |
05/01/2023 | 8.89% | Keefe, Bruyette & Woods | $34 → $31 | Maintains | Underperform |
04/12/2023 | 26.45% | Morgan Stanley | $29 → $36 | Upgrades | Underweight → Equal-Weight |
01/10/2023 | 86.16% | JMP Securities | $56 → $53 | Maintains | Market Outperform |
10/31/2022 | 1.86% | Morgan Stanley | $28 → $29 | Maintains | Underweight |
08/04/2022 | 26.45% | Goldman Sachs | $32 → $36 | Maintains | Neutral |
07/18/2022 | 5.37% | Morgan Stanley | $40 → $30 | Downgrades | Equal-Weight → Underweight |
07/13/2022 | 5.37% | Keefe, Bruyette & Woods | $38 → $30 | Downgrades | Market Perform → Underperform |
07/08/2022 | 54.55% | Piper Sandler | $45 → $44 | Maintains | Overweight |
04/07/2022 | 58.06% | Piper Sandler | $49 → $45 | Maintains | Overweight |
04/07/2022 | 96.7% | JMP Securities | $58 → $56 | Maintains | Market Outperform |
04/07/2022 | 36.99% | Wolfe Research | → $39 | Downgrades | Peer Perform → Underperform |
03/09/2022 | 82.65% | Piper Sandler | $62 → $52 | Maintains | Overweight |
03/08/2022 | 40.5% | Morgan Stanley | → $40 | Downgrades | Overweight → Equal-Weight |
02/04/2022 | 72.11% | Keefe, Bruyette & Woods | $52 → $49 | Downgrades | Outperform → Market Perform |
01/04/2022 | 51.04% | UBS | $47 → $43 | Maintains | Neutral |
12/08/2021 | 93.19% | Morgan Stanley | $61 → $55 | Maintains | Overweight |
10/01/2021 | 103.72% | Keefe, Bruyette & Woods | $53 → $58 | Upgrades | Market Perform → Outperform |
05/03/2021 | 72.11% | Credit Suisse | $50 → $49 | Maintains | Neutral |
04/12/2021 | 75.62% | Credit Suisse | $49 → $50 | Maintains | Neutral |
04/07/2021 | 114.26% | Morgan Stanley | → $61 | Upgrades | Equal-Weight → Overweight |
01/14/2021 | 75.62% | Keefe, Bruyette & Woods | → $50 | Downgrades | Outperform → Market Perform |
12/16/2020 | 72.11% | Seaport Global | → $49 | Initiates Coverage On | → Buy |
12/14/2020 | 82.65% | Morgan Stanley | $39 → $52 | Upgrades | Underweight → Equal-Weight |
10/12/2020 | 36.99% | Morgan Stanley | $29 → $39 | Maintains | Underweight |
10/09/2020 | 47.52% | JMP Securities | $40 → $42 | Maintains | Market Outperform |
08/03/2020 | 1.86% | Morgan Stanley | $28 → $29 | Maintains | Underweight |
08/03/2020 | 19.42% | Credit Suisse | $32 → $34 | Maintains | Neutral |
06/23/2020 | 12.4% | Credit Suisse | → $32 | Initiates Coverage On | → Neutral |
05/06/2020 | 22.94% | Argus Research | $51 → $35 | Maintains | Buy |
05/04/2020 | -15.7% | UBS | $23 → $24 | Maintains | Neutral |
05/01/2020 | -15.7% | CFRA | $22 → $24 | Maintains | Sell |
04/24/2020 | -22.73% | CFRA | $46 → $22 | Downgrades | Hold → Sell |
04/09/2020 | 40.5% | JMP Securities | $50 → $40 | Maintains | Market Outperform |
04/09/2020 | -1.65% | Morgan Stanley | $39 → $28 | Maintains | Underweight |
03/25/2020 | -19.21% | UBS | $41 → $23 | Maintains | Neutral |
01/31/2020 | 61.57% | CFRA | $43 → $46 | Maintains | Hold |
01/27/2020 | 68.6% | Keefe, Bruyette & Woods | $40 → $48 | Upgrades | Market Perform → Outperform |
01/13/2020 | 61.57% | Buckingham Research | $40 → $46 | Maintains | Neutral |
01/06/2020 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
11/20/2019 | 22.94% | Morgan Stanley | → $35 | Initiates Coverage On | → Underweight |
10/09/2019 | 40.5% | Buckingham Research | $41 → $40 | Maintains | Neutral |
07/11/2019 | 44.01% | Buckingham Research | $45 → $41 | Maintains | Neutral |
06/10/2019 | — | UBS | Downgrades | Buy → Neutral | |
04/11/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
11/06/2018 | 61.57% | Goldman Sachs | → $46 | Initiates Coverage On | → Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
2023年10月27日 | 58.06% | 摩根士丹利 | $41→$45 | 维护 | 超重 |
2023年10月12日 | 44.01% | 摩根士丹利 | $42→$41 | 维护 | 超重 |
2023年10月10日 | 75.62% | JMP证券 | $53→$50 | 维护 | 市场表现强于大盘 |
10/03/2023 | 12.4% | 瑞银集团 | $37→$32 | 维护 | 中性 |
09/26/2023 | 47.52% | 摩根士丹利 | $44→$42 | 维护 | 超重 |
2023/09/19 | 12.4% | 高盛 | $37→$32 | 评级下调 | 中性→销售 |
07/31/2023 | 29.96% | 瑞银集团 | $32→$37 | 维护 | 中性 |
07/14/2023 | 51.04% | 摩根士丹利 | $43→$43 | 重申 | 超重→超重 |
07/13/2023 | - | Keefe,Bruyette&Wood | 升级 | 表现逊于→市场表现 | |
07/12/2023 | 51.04% | 摩根士丹利 | $36→$43 | 升级 | 等重→超重 |
07/10/2023 | 86.16% | JMP证券 | →$53 | 重申 | 市场表现优于→市场表现 |
07/03/2023 | - | 沃尔夫研究 | 升级 | 表现不佳的→对等设备 | |
2023年05月22日 | 86.16% | JMP证券 | $53→$53 | 重申 | 市场表现优于→市场表现 |
05/01/2023 | 8.89% | Keefe,Bruyette&Wood | $34→$31 | 维护 | 表现不佳 |
04/12/2023 | 26.45% | 摩根士丹利 | $29→$36 | 升级 | 重量不足的→等重 |
2023年1月10日 | 86.16% | JMP证券 | $56→$53 | 维护 | 市场表现强于大盘 |
2022年10月31日 | 1.86% | 摩根士丹利 | $28→$29 | 维护 | 体重不足 |
08/04/2022 | 26.45% | 高盛 | $32→$36 | 维护 | 中性 |
07/18/2022 | 5.37% | 摩根士丹利 | $40→$30 | 评级下调 | 等重→减码 |
07/13/2022 | 5.37% | Keefe,Bruyette&Wood | $38→$30 | 评级下调 | 市场表现→表现不佳 |
07/08/2022 | 54.55% | 派珀·桑德勒 | $45→$44 | 维护 | 超重 |
04/07/2022 | 58.06% | 派珀·桑德勒 | $49→$45 | 维护 | 超重 |
04/07/2022 | 96.7% | JMP证券 | $58→$56 | 维护 | 市场表现强于大盘 |
04/07/2022 | 36.99% | 沃尔夫研究 | →$39 | 评级下调 | 同行执行→表现不佳 |
03/09/2022 | 82.65% | 派珀·桑德勒 | $62→$52 | 维护 | 超重 |
03/08/2022 | 40.5% | 摩根士丹利 | →$40 | 评级下调 | 超重→等重 |
02/04/2022 | 72.11% | Keefe,Bruyette&Wood | $52→$49 | 评级下调 | 跑赢→市场表现 |
01/04/2022 | 51.04% | 瑞银集团 | $47→$43 | 维护 | 中性 |
12/08/2021 | 93.19% | 摩根士丹利 | $61→$55 | 维护 | 超重 |
10/01/2021 | 103.72% | Keefe,Bruyette&Wood | $53→$58 | 升级 | 市场表现优于→ |
05/03/2021 | 72.11% | 瑞士信贷 | $50→$49 | 维护 | 中性 |
04/12/2021 | 75.62% | 瑞士信贷 | $49→$50 | 维护 | 中性 |
04/07/2021 | 114.26% | 摩根士丹利 | →$61 | 升级 | 等重→超重 |
2021/01/14 | 75.62% | Keefe,Bruyette&Wood | →$50 | 评级下调 | 跑赢→市场表现 |
12/16/2020 | 72.11% | 环球海港 | →$49 | 开始承保 | →购买 |
12/14/2020 | 82.65% | 摩根士丹利 | $39→$52 | 升级 | 重量不足的→等重 |
10/12/2020 | 36.99% | 摩根士丹利 | $29→$39 | 维护 | 体重不足 |
10/09/2020 | 47.52% | JMP证券 | $40→$42 | 维护 | 市场表现强于大盘 |
08/03/2020 | 1.86% | 摩根士丹利 | $28→$29 | 维护 | 体重不足 |
08/03/2020 | 19.42% | 瑞士信贷 | $32→$34 | 维护 | 中性 |
2020/06/23 | 12.4% | 瑞士信贷 | →$32 | 开始承保 | →中性 |
05/06/2020 | 22.94% | Argus研究 | $51→$35 | 维护 | 买 |
05/04/2020 | -15.7% | 瑞银集团 | $23→$24 | 维护 | 中性 |
05/01/2020 | -15.7% | CFRA | $22→$24 | 维护 | 卖 |
04/24/2020 | -22.73% | CFRA | $46→$22 | 评级下调 | 持有→Sell |
04/09/2020 | 40.5% | JMP证券 | $50→$40 | 维护 | 市场表现强于大盘 |
04/09/2020 | -1.65% | 摩根士丹利 | $39→$28 | 维护 | 体重不足 |
03/25/2020 | -19.21% | 瑞银集团 | $41→$23 | 维护 | 中性 |
2020/01/31 | 61.57% | CFRA | $43→$46 | 维护 | 保持 |
2020/01/27 | 68.6% | Keefe,Bruyette&Wood | $40→$48 | 升级 | 市场表现优于→ |
2020/01/13 | 61.57% | 白金汉研究 | $40→$46 | 维护 | 中性 |
01/06/2020 | - | 沃尔夫研究 | 升级 | 表现不佳的→对等设备 | |
2019年11月20日 | 22.94% | 摩根士丹利 | →$35 | 开始承保 | →减持 |
2019年10月09日 | 40.5% | 白金汉研究 | $41→$40 | 维护 | 中性 |
2019年07月11日 | 44.01% | 白金汉研究 | $45→$41 | 维护 | 中性 |
2019年06月10日 | - | 瑞银集团 | 评级下调 | 购买→中性 | |
2019年4月11日 | - | B of A证券 | 评级下调 | 购买→中性 | |
2018/06/11 | 61.57% | 高盛 | →$46 | 开始承保 | →中性 |
What is the target price for Lazard (LAZ)?
拉扎德(Lazard)的目标价是多少?
The latest price target for Lazard (NYSE: LAZ) was reported by Morgan Stanley on October 27, 2023. The analyst firm set a price target for $45.00 expecting LAZ to rise to within 12 months (a possible 58.06% upside). 17 analyst firms have reported ratings in the last year.
Lazard(纽约证券交易所代码:LAZ)的最新目标价由摩根士丹利于2023年10月27日报道。这家分析公司将目标价定为45.00美元,预计LAZ将在12个月内升至(可能上涨58.06%)。过去一年,17家分析公司公布了评级。
What is the most recent analyst rating for Lazard (LAZ)?
Lazard(LAZ)的最新分析师评级是多少?
The latest analyst rating for Lazard (NYSE: LAZ) was provided by Morgan Stanley, and Lazard maintained their overweight rating.
分析师对Lazard(纽约证券交易所代码:LAZ)的最新评级由摩根士丹利提供,Lazard维持其增持评级。
When is the next analyst rating going to be posted or updated for Lazard (LAZ)?
Lazard(LAZ)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lazard, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lazard was filed on October 27, 2023 so you should expect the next rating to be made available sometime around October 27, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Lazard的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Lazard的上一次评级是在2023年10月27日提交的,所以你应该预计下一次评级将在2024年10月27日左右提供。
Is the Analyst Rating Lazard (LAZ) correct?
分析师评级Lazard(LAZ)正确吗?
While ratings are subjective and will change, the latest Lazard (LAZ) rating was a maintained with a price target of $41.00 to $45.00. The current price Lazard (LAZ) is trading at is $28.47, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的Lazard(LAZ)评级维持不变,目标价在41.00美元至45.00美元之间。Lazard(LAZ)目前的交易价格为28.47美元,超出了分析师的预测区间。